<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">6875</item><item key="factors"><item><item key="GSM928277"><item key="FACS SORTED FOR">dsRed2+ and TTP-GFP-</item><item key="VARIATION">MSCV-I-dsRed2+; MSCV-TTP-I-GFP-</item></item></item><item><item key="GSM928277"><item key="FACS SORTED FOR">dsRed2+ and TTP-GFP-</item><item key="VARIATION">MSCV-I-dsRed2+; MSCV-TTP-I-GFP-</item></item></item><item><item key="GSM928277"><item key="FACS SORTED FOR">dsRed2+ and TTP-GFP-</item><item key="VARIATION">MSCV-I-dsRed2+; MSCV-TTP-I-GFP-</item></item></item><item><item key="GSM928280"><item key="FACS SORTED FOR">dsRed2+ and TTP-GFP+</item><item key="VARIATION">MSCV-I-dsRed2+; MSCV-TTP-I-GFP+</item></item></item><item><item key="GSM928280"><item key="FACS SORTED FOR">dsRed2+ and TTP-GFP+</item><item key="VARIATION">MSCV-I-dsRed2+; MSCV-TTP-I-GFP+</item></item></item><item><item key="GSM928280"><item key="FACS SORTED FOR">dsRed2+ and TTP-GFP+</item><item key="VARIATION">MSCV-I-dsRed2+; MSCV-TTP-I-GFP+</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">Myc oncoproteins directly regulate transcription by binding to target genes, yet this only explains a fraction of the genes affected by...</item><item key="pubmed_id">22863009</item><item key="geo_gse_id">E-GEOD-37791</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>cancer</item><item>lymphoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">tristetraprolin-is-a-tumor-suppressor-that-impai-3</item><item key="geo_id_plat">E-GEOD-37791_A-AFFY-45</item><item key="name">Tristetraprolin is a tumor suppressor that impairs Myc-induced lymphoma and abolishes the malignant state [retrovirally infected ex vivo lymphoma]</item><item key="created">Nov.12, 2014</item><item key="summary">Myc oncoproteins directly regulate transcription by binding to target genes, yet this only explains a fraction of the genes affected by Myc. mRNA turnover is controlled via AU-binding proteins (AUBPs) that recognize AU-rich elements (AREs) found within many transcripts. Analyses of precancerous and malignant Myc-expressing B cells revealed that Myc regulates hundreds of ARE-containing (ARED) genes and select AUBPs. Notably, Myc directly suppresses transcription of Tristetraprolin (TTP/ZFP36), an mRNA-destabilizing AUBP, and this circuit is also operational during B lymphopoiesis and IL7 signaling. Importantly, TTP suppression is a hallmark of cancers with MYC involvement, and restoring TTP impairs Myc-induced lymphomagenesis and abolishes maintenance of the malignant state. Further, there is a selection for TTP loss in malignancy; thus, TTP functions as a tumor suppressor. Finally, Myc/TTP-directed control of select cancer-associated ARED genes is disabled during lymphomagenesis. Thus, Myc targets AUBPs to regulate ARED genes that control tumorigenesis. Ex vivo E&#956;-Myc lymphoma cells were infected with MSCV-I-dsRed2 (RFP) and FACS sorted for dsRed2+ cells. These cells were then infected with MSCV-TTP-I-GFP and FACS sorted for GFP expression (TTP-GFP- or TTP-GFP+). These cells were used for subsequent RNA purification, labeling and hybridization to MOE430 2.0 Affymetrix arrays.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-37791</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-37791/samples/</item></data></biogps>
